Related Experiment Video
Updated: Jul 8, 2026

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis
Published on: May 22, 2018
Thiol compounds inhibit the formation of amyloid fibrils by beta 2-microglobulin at neutral pH
Kaori Yamamoto1, Hisashi Yagi, Daisaku Ozawa
1Institute for Protein Research, Osaka University, and CREST, Japan Science and Technology Agency, Yamadaoka 3-2, Suita, Osaka 565-0871, Japan.
Abstract:
Dialysis-related amyloidosis frequently develops in patients undergoing long-term hemodialysis, in which the major component of fibrils is beta(2)-microglobulin (beta2-m). To prevent the disease, it is important to stop the formation of fibrils. beta2-m has one disulfide bond, which stabilizes the native structure, and amyloid fibrils. Here, the effects of reductants (i.e., dithiothreitol and cysteine) on the formation of beta2-m amyloid fibrils were examined at neutral pH. Fibrils were generated by three methods: seed-dependent, ultrasonication-induced, and salt-and-heat-induced fibrillation. Thioflavin T fluorescence, electron microscopy, and far-UV circular dichroism revealed that the addition of reductants significantly inhibits seed-dependent and ultrasonication-induced fibrillation. For salt-and-heat-induced fibrillation, where the solution of beta2-m was strongly agitated, formation of amyloid fibrils was markedly reduced in the presence of reductants, although a small number of fibrils formed even after the reduction of the disulfide bond. The results suggest that reductants such as cysteine and dithiothreitol would be useful for preventing the formation of beta2-m amyloid fibrils under physiological conditions.
Insights
Reductants like dithiothreitol and cysteine can prevent beta(2)-microglobulin (beta2-m) amyloid fibril formation. This finding offers a potential strategy to inhibit dialysis-related amyloidosis in patients undergoing long-term hemodialysis.
Area of Science:
- Biochemistry
- Medical Science
- Protein Chemistry
Background:
- Dialysis-related amyloidosis is common in long-term hemodialysis patients.
- Beta(2)-microglobulin (beta2-m) is the primary component of amyloid fibrils in this condition.
- Beta(2)-m's disulfide bond stabilizes its native structure and amyloid fibrils.
Purpose of the Study:
- To investigate the effect of reductants on beta(2)-m amyloid fibril formation.
- To explore potential preventative strategies for dialysis-related amyloidosis.
Main Methods:
- Examined the impact of dithiothreitol and cysteine on beta(2)-m fibrillation at neutral pH.
- Utilized seed-dependent, ultrasonication-induced, and salt-and-heat-induced fibrillation methods.
- Assessed fibril formation using Thioflavin T fluorescence, electron microscopy, and circular dichroism.
Main Results:
- Reductants significantly inhibited seed-dependent and ultrasonication-induced beta(2)-m fibrillation.
- Amyloid fibril formation was markedly reduced in salt-and-heat-induced fibrillation with reductants.
- A small number of fibrils still formed even after disulfide bond reduction in agitated conditions.
Conclusions:
- Reductants like cysteine and dithiothreitol show promise in preventing beta(2)-m amyloid fibril formation.
- These reductants could be beneficial for inhibiting dialysis-related amyloidosis under physiological conditions.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
Inhibitors of Bacterial Protein Synthesis
Antiprotozoal Agents

